Correlation Between Elevance Health and CRISPR Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Elevance Health and CRISPR Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Elevance Health and CRISPR Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Elevance Health and CRISPR Therapeutics AG, you can compare the effects of market volatilities on Elevance Health and CRISPR Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Elevance Health with a short position of CRISPR Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Elevance Health and CRISPR Therapeutics.

Diversification Opportunities for Elevance Health and CRISPR Therapeutics

-0.63
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Elevance and CRISPR is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding Elevance Health and CRISPR Therapeutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CRISPR Therapeutics and Elevance Health is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Elevance Health are associated (or correlated) with CRISPR Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CRISPR Therapeutics has no effect on the direction of Elevance Health i.e., Elevance Health and CRISPR Therapeutics go up and down completely randomly.

Pair Corralation between Elevance Health and CRISPR Therapeutics

Considering the 90-day investment horizon Elevance Health is expected to generate 0.4 times more return on investment than CRISPR Therapeutics. However, Elevance Health is 2.49 times less risky than CRISPR Therapeutics. It trades about 0.07 of its potential returns per unit of risk. CRISPR Therapeutics AG is currently generating about -0.02 per unit of risk. If you would invest  33,283  in Elevance Health on August 28, 2022 and sell it today you would earn a total of  18,103  from holding Elevance Health or generate 54.39% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy99.77%
ValuesDaily Returns

Elevance Health  vs.  CRISPR Therapeutics AG

 Performance (%) 
       Timeline  
Elevance Health 
Elevance Performance
4 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Elevance Health are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable essential indicators, Elevance Health is not utilizing all of its potentials. The new stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Elevance Price Channel

CRISPR Therapeutics 
CRISPR Performance
0 of 100
Over the last 90 days CRISPR Therapeutics AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2022. The recent disarray may also be a sign of long period up-swing for the firm insiders.

CRISPR Price Channel

Elevance Health and CRISPR Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Elevance Health and CRISPR Therapeutics

The main advantage of trading using opposite Elevance Health and CRISPR Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Elevance Health position performs unexpectedly, CRISPR Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CRISPR Therapeutics will offset losses from the drop in CRISPR Therapeutics' long position.
Elevance Health vs. Humana Inc
Elevance Health vs. Centene Corp
Elevance Health vs. Molina Healthcare
Elevance Health vs. Unitedhealth Group
The idea behind Elevance Health and CRISPR Therapeutics AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
CRISPR Therapeutics vs. Regeneron Pharmaceuticals
CRISPR Therapeutics vs. Vertex Pharmaceutic
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Complementary Tools

Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go